Anxiety

(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc (NASDAQ: ATAI) (–AtaiBeckley– or the–Company–), a clinical-stage biotechnology company on a mission to ...

LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials that could reshape care.

In fiscal year 2025, UNC School of Medicine researchers led the drive toward important discoveries aimed at improving human health and the lives of people in North Carolina. Our researchers remain dedicated to UNC’s broader research missions by preventing and curing disease, optimizing brain health and well-being, and applying artificial intelligence to benefit and save lives.Continue reading

Getting stuck in a negative loop is part of many mental health disorders. A new therapy focuses more on these thought patterns than the thoughts themselves.

While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exerciseProf Devi Sridhar is chair of global public health at the University of EdinburghIf there has been a hot topic in health in 2025, it’s definitely been GLP-1s, colloquially referred to as “anti-obesity” jabs. These medications, taken weekly as an injection into the abdomen, result in significant weight loss and, despite being developed to manage type 2 diabetes in those with

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being approved for the common mental health condition